A year ago, MB Therapeutics started its adventure with a clear mission: to bring innovative solutions to the healthcare field. Today, we celebrate a year rich in achievements, marked by strong partnerships, an ambitious strategic roadmap, and a structured team for the future.

A first year of innovation and growth

Since its creation, MB Therapeutics has made significant progress:

• Strategic partnerships: We have developed lasting relationships with our partners, particularly with pharmacists, a key player in the healthcare ecosystem. These partnerships strengthen our capacity to offer innovative therapeutic solutions and to accelerate their market adoption.

• 2026 Vision Roadmap: From this first year, we initiated our long-term strategic plan, vision 2026. This roadmap sets clear objectives to strengthen our role in therapeutic innovation. MB Therapeutics is committed to long-term innovation in order to offer more effective, personalized, and accessible treatments to every patient.

• Team structuring: We have set up an expert and passionate team , aligned with MB values and goals. Thanks to this team, we have the necessary resources to execute our projects with efficiency and rigor.

The promising future of MB Therapeutics

While we celebrate our first anniversary today, MB Therapeutics remains resolutely focused on the future. The coming years will be marked by major advances in the implementation of our 2026 vision, as well as the introduction of new innovative therapeutic solutions on the market.

Our commitment is to continue innovating in the healthcare field by establishing new strategic partnerships and without losing sight of our slogan: MADE FOR YOU MEDS, to each their own medicine.

THANK YOU to those who contribute to our success

We would like to warmly thank our clients, partners, and team members. Thanks to you, MB Therapeutics is able to pursue its commitment to the medicine of tomorrow, which is ever more innovative and effective.

Today, we are proud to develop a turnkey solution for the production of new generation personalized medicines in pharmacies. A huge thank you to the pharmacists who believe in the future of 3D printing of medicines, and who accompany us every day to offer their patients custom-made treatments.

Ian Soulairol & Stéphane Roulon, Co-founders of MB Therapeutics